Oral Oncology
Volume 40, Issue 1 , Pages 21-27, January 2004

Heme oxygenase-1 expression predicts cervical lymph node metastasis of tongue squamous cell carcinomas

  • Toru Yanagawa

      Affiliations

    • Department of Oral and Maxillofacial Surgery, Institute of Clinical Medicine, University of Tsukuba, 1-1-1 Tennodai, Tsukuba-shi, Ibaraki-ken, 305-8575, Japan
    • Corresponding Author InformationCorresponding author. Tel./Fax: +81-29-853-3052
  • ,
  • Ken Omura

      Affiliations

    • Oral Surgery, Department of Oral Restitution, Division of Oral Health Sciences, Graduate School, Tokyo Medical and Dental University, Tokyo, Japan
  • ,
  • Hiroyuki Harada

      Affiliations

    • Oral Surgery, Department of Oral Restitution, Division of Oral Health Sciences, Graduate School, Tokyo Medical and Dental University, Tokyo, Japan
  • ,
  • Kazuhiro Nakaso

      Affiliations

    • Division of Neurology, Faculty of Medicine, Tottori University, Tottori, Japan
  • ,
  • Satoshi Iwasa

      Affiliations

    • Department of Pathology, Nihon University School of Medicine, Tokyo, Japan
  • ,
  • Yumi Koyama

      Affiliations

    • Department of Clinical Pharmaceutics, College of Pharmacy, Nihon University, Funabashi, Japan
  • ,
  • Kojiro Onizawa

      Affiliations

    • Department of Oral and Maxillofacial Surgery, Institute of Clinical Medicine, University of Tsukuba, 1-1-1 Tennodai, Tsukuba-shi, Ibaraki-ken, 305-8575, Japan
  • ,
  • Hiroshi Yusa

      Affiliations

    • Department of Oral and Maxillofacial Surgery, Institute of Clinical Medicine, University of Tsukuba, 1-1-1 Tennodai, Tsukuba-shi, Ibaraki-ken, 305-8575, Japan
  • ,
  • Hiroshi Yoshida

      Affiliations

    • Department of Oral and Maxillofacial Surgery, Institute of Clinical Medicine, University of Tsukuba, 1-1-1 Tennodai, Tsukuba-shi, Ibaraki-ken, 305-8575, Japan

Received 12 May 2003; accepted 27 May 2003.

Abstract 

Heme oxygenase-1 (HO-1) is known as a stress-inducible protein. The present study was designed to investigate the relationship between HO-1 expression levels and clinical features of tongue cancer by using HO-1 responsiveness to stress as a clinical indicator. One-hundred and twelve biopsy samples from tongue squamous cell carcinomas were analyzed semiquantitatively by immunohistochemistry. Correlations between the expression level of HO-1 and the clinical features of tumors were statistically analyzed. Fifty-four cases with surgical confirmation of lymph node metastasis were examined for the association between cervical lymph node metastasis (pN) and other clinical features, including the HO-1 expression level, using logistic regression. The low HO-1 expression group contained significantly more undifferentiated samples (P=0.04) and pN positive cases (P=0.01) by univariate analysis. The low HO-1 expression group (odds ratio=8.49; 95% confidence interval=1.64–44.09, P=0.01) and an endophytic shape (odds ratio=16.79; 95% confidence interval=1.77–159.53, P=0.01) were significantly associated with an increased risk of developing lymph node metastasis by multivariate analysis. Low HO-1 expression was associated with lymph node metastasis. The expression profile suggests HO-1 could be used clinically as a marker for tumors possessing the potential for lymph node metastasis. This method could prove useful as an adjuvant method to detect lymph node metastasis and may help reduce the number of surgeries by indicating when surgery is unnecessary.

Keywords:  Heme oxygenase-1, Squamous cell carcinoma, Tongue cancer, Lymph node metastasis

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S1368-8375(03)00128-3

doi:10.1016/S1368-8375(03)00128-3

Oral Oncology
Volume 40, Issue 1 , Pages 21-27, January 2004